Jimenez John T
Known title: Chief Financial OfficerCIK: 0001954238
Jimenez John T's purchase track record
Jimenez John T has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/27/2024 | BKV | $297K | +24.8% | +14.9% | -2.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BKV | ▼ Sell | Tax Withholding | 3,787 | $90K | 1/2/2025 | View on chart |
| BKV | ▼ Sell | Tax Withholding | 7,604 | $137K | 9/27/2024 | View on chart |
| BKV | ▲ Buy | Open Market | 16,500 | $297K | 9/27/2024 | View on chart |
| BKV | ▲ Buy | Grant | 35,555 | $0 | 9/27/2024 | View on chart |
| BKV | ▼ Sell | Tax Withholding | 147,399 | $4.2M | 8/22/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
BKV Shares Rise on Texas Power Deal and Q2 Earnings
BKV Corporation stock has seen significant gains, including a 12.4% jump, following news of a 1,200 MW power deal in Texas backed by a hyperscaler. The company also reported its Q2 2026 earnings and signed an equipment supply contract for a potential Texas project. These developments have driven the stock higher, with analysts maintaining an average price target of $34.09.
BKV Shares Rise on Texas Power Deal and Q2 Earnings. BKV Corporation stock has seen significant gains, including a 12.4% jump, following news of a 1,200 MW power deal in Texas backed by a hyperscaler. The company also reported its Q2 2026 earnings and signed an equipment supply contract for a potential Texas project. These developments have driven the stock higher, with analysts maintaining an average price target of $34.09.